We would like to share some of the latest developments in the industry and provide an outlook of some of our key activities. If you would like to receive this update straight to your inbox, please feel free to sign up to our monthly newsletter.
Industry News
Advancing Biopharmaceutical Manufacturing
Economic and Sustainability Assessment of End-to-end Continuous Production of Monoclonal Antibodies
A recent study published in the journal ‘Trends in Biotechnology’ indicates that a continuous manufacturing process can reduce total annual production costs, facility footprint, plastic waste, and CO2 emissions by up to 23%, 51%, 57%, and 54%, respectively compared to a best-in-class fed-batch process.
News at Just - Evotec Biologics
How Continuous Biomanufacturing Can Transform Biologics Production
In a recent article published in the European Biopharmaceutical Review (EBR), we explore how our continuous manufacturing platform and modular, small-footprint facilities are paving the way for a more efficient and accessible future in biologics production.
Innovation and Advances in the BioPharma Space
This ebook by The Medicine Maker and sponsored by Just – Evotec Biologics covers evolutions in the space from developments in cell culture media to enhancing the potency of monoclonal antibodies and continuous biomanufacturing.
Conferences
We end the year on a high note.. earlier this month we presented on the main stage at the Biomanufacturing World Summit in San Diego! What better way is there to present our continuous biomanufacturing platform?
The year of 2024 may almost be over, but we look forward to meeting you again in-person next year!
Until then, feel free to follow us on LinkedIn!
